|
|
|
Insider
Information: |
Boyce Sarah |
Relationship: |
Director |
City: |
Carlsbad |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
191,418 |
|
Indirect Shares
|
36,000 |
|
|
Direct
Value |
$4,141,955 |
|
|
Indirect Value
|
$167,040 |
|
|
Total
Shares |
227,418 |
|
|
Total
Value |
$4,308,995 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
4
|
Stock
price went up :
|
2
|
3
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
2.0
|
3.0
|
Percentage
Gain/Loss : |
86.2%
|
62.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ionis Pharmaceuticals Inc |
IONS |
Chief Business Officer |
2018-01-16 |
8,931 |
2016-01-01 |
0 |
Premium* |
|
Akcea Therapeutics Inc |
AKCA |
President, Director |
2019-07-15 |
19,888 |
2018-04-17 |
0 |
Premium* |
|
Ligand Pharmaceuticals Inc |
LGND |
Former Director |
2022-11-01 |
2,892 |
2019-10-15 |
0 |
Premium* |
|
Berkeley Lights, Inc. |
BLI |
Director |
2021-05-14 |
1,400 |
2021-03-01 |
0 |
Premium* |
|
Avidity Biosciences, Inc. |
RNA |
President and CEO, Dir... |
2024-06-04 |
112,117 |
2022-08-15 |
0 |
Premium* |
|
OmniAb, Inc |
OABI |
Director |
2023-01-30 |
46,190 |
2023-01-30 |
36,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2024-03-08 |
4 |
S |
$21.39 |
$1,796,710 |
D/D |
(84,000) |
112,117 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2024-03-01 |
4 |
S |
$20.13 |
$1,691,306 |
D/D |
(84,000) |
112,117 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2023-02-02 |
4 |
AS |
$24.36 |
$1,117,741 |
D/D |
(45,879) |
53,352 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2022-08-24 |
4 |
AS |
$22.80 |
$798,924 |
D/D |
(35,045) |
0 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2024-06-04 |
4 |
AS |
$27.42 |
$767,780 |
D/D |
(28,000) |
112,117 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2024-04-02 |
4 |
S |
$26.25 |
$734,919 |
D/D |
(28,000) |
112,117 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2024-05-07 |
4 |
AS |
$25.54 |
$715,050 |
D/D |
(28,000) |
112,117 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2024-03-12 |
4 |
S |
$22.63 |
$633,682 |
D/D |
(28,000) |
112,117 |
0 |
% |
|
BLI |
Berkeley Lights, Inc. |
Director |
|
2021-03-01 |
4 |
AS |
$60.08 |
$611,337 |
D/D |
(10,000) |
0 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2022-08-25 |
4 |
AS |
$23.07 |
$342,690 |
D/D |
(14,855) |
0 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Business Officer |
|
2018-01-16 |
4 |
S |
$51.76 |
$113,665 |
D/D |
(2,196) |
8,931 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2024-03-01 |
4 |
OE |
$1.24 |
$104,160 |
D/D |
84,000 |
196,117 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2024-03-08 |
4 |
OE |
$1.24 |
$104,160 |
D/D |
84,000 |
196,117 |
0 |
- |
|
BLI |
Berkeley Lights, Inc. |
Director |
|
2021-03-01 |
4 |
OE |
$8.90 |
$89,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2023-02-03 |
4 |
AS |
$24.26 |
$78,141 |
D/D |
(3,221) |
53,352 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Business Officer |
|
2017-01-17 |
4 |
S |
$46.29 |
$63,001 |
D/D |
(1,361) |
5,252 |
0 |
- |
|
OABI |
OmniAb, Inc |
Director |
|
2022-11-09 |
4 |
B |
$2.74 |
$57,597 |
I/I |
21,000 |
21,000 |
2.1 |
% |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2023-02-02 |
4 |
OE |
$1.24 |
$56,890 |
D/D |
45,879 |
99,231 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2024-01-22 |
4 |
AS |
$10.13 |
$51,582 |
D/D |
(5,092) |
44,008 |
0 |
% |
|
OABI |
OmniAb, Inc |
Director |
|
2022-11-10 |
4 |
B |
$2.92 |
$43,800 |
I/I |
15,000 |
36,000 |
2.1 |
% |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2022-08-24 |
4 |
OE |
$1.24 |
$43,456 |
D/D |
35,045 |
35,045 |
0 |
- |
|
AKCA |
Akcea Therapeutics Inc |
President |
|
2019-07-15 |
4 |
S |
$23.52 |
$42,783 |
D/D |
(1,819) |
19,888 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Business Officer |
|
2016-01-19 |
4 |
S |
$41.46 |
$36,151 |
D/D |
(872) |
1,735 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2024-03-12 |
4 |
OE |
$1.24 |
$34,720 |
D/D |
28,000 |
140,117 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
President and CEO |
|
2024-04-02 |
4 |
OE |
$1.24 |
$34,720 |
D/D |
28,000 |
140,117 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|